The research project is testing a new treatment for participants with locally advanced or metastatic non-clear cell kidney cancer. The new treatment involves a drug called Cabozantinib (also known as Cabometyx). This drug has been used previously in many cancers, including clear cell kidney cancer and thyroid cancer.
ANZUP – Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)
Sponsor / Cooperative group: